People all over the world are living longer, which is making the Bone Density Test Market grow. As people age, they are more likely to get osteoporosis and other diseases linked to it. To keep an eye on bone health and harm risk, bone density checks are needed.
What changes the market is the number of people with osteoporosis or osteopenia. When these things happen, bones get weaker and more likely to break. These tests can find bone problems early and fix them, which makes the market bigger.
Many menopausal women receive bone density testing. Due to hormone changes that induce bone loss, menopause increases osteoporosis risk. This group should have frequent bone density examinations to determine their risk of breaking a bone and how to prevent it.
Changes in bone densitometry affect the market. Due to new imaging technologies like DXA, bone density testing are more accurate and reliable for patients and clinicians. The bone density test business is changed by AI in testing. It is now easier to handle and understand bone density scans thanks to AI. This helps doctors make better decisions about bone health.
The market is growing because more people are learning about bone health and getting checked out regularly. The market grows because annual bone density checks are pushed by public health as a way to keep people healthy.
Issues with bone health can be caused by bad food, not moving around much, and a lazy way of life. Now that people know how lifestyle affects bone density, they want bone density tests to find and treat lifestyle problems.
Because bone density tests are so important in orthopedics and gout, the business is driven by them. Rheumatologists and orthopedic doctors use bone density to see who is most likely to break a bone, plan care, and keep an eye on how drugs affect bone health.
Because of steps the government and public health are taking to fight osteoporosis, the business of bone density tests is growing. More people get checked for bone health issues when they know about the tests that can be done.
Ability to get health care and money for it both affect how many bone density tests are sold. Health care professionals offer bone density tests when they are paid enough. But money problems could make it hard to use, especially in some places.
Even though there are good market forces at work, there are problems with patients following through on their appointments and tests. People who want to improve their bone health must follow the lifestyle and drug ideas that are made based on the results of their tests.
The Bone Density Test Market is used in medical medicine to find out about bone health and the chance of getting hurt. Health care companies must come to smart deals in order to place themselves in the market. Bone density test companies work with clinics, hospitals, and imaging centers to make their services a normal part of health care. These deals make professional bone density tests better and help them reach more people.
Compact and point-of-care bone density measuring tools are made so that they are easy to use and easy to get to. These small, simple technologies let doctors do tests right away for people who want accurate tools, which grows the market share.
Report Attribute/Metric | Details |
---|---|
Growth Rate | Â Â 6.01% |
Bone Density Test Market Size was valued at USD 1.17 Billion in 2023. The Global Bone Density Test industry is projected to grow from USD 1.22 Billion in 2024 to USD 1.75 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.77% during the forecast period (2024 - 2032).
The Bone density test market is inclusive of the tests that help in determining the density of bones and chances of the bone being broken. A central dual-energy X-ray absorptiometry (DXA) test is recommended by the experts for the test of the bone density of the hip and spine of various patients. These tests can be conducted for a series of reasons. Bone density test is used in the diagnosis of issues like osteoporosis, and osteopenia. Osteoporosis mostly occurs in the women population after menopause but may also be present in the male population. However, the condition is less common in adults and children.
In January 2024, a research experiment conducted by Mayo Clinic will be included in a payload that will be launched into orbit from NASA's Kennedy orbit Center at Cape Canaveral, Florida, contingent upon weather conditions and other variables. The study team is currently preparing stem cells for transport on the journey in order to investigate the impact of zero gravity on bone density reduction. The research project aims to investigate the impact of gravity on mesenchymal stem cells, a specific type of adult stem cells produced from bone marrow, which possess growth factors and the ability to promote healing. They have a crucial function in the process of tissue repair and regeneration. The research will take place throughout two space missions. The inaugural space mission will assess the effects of microgravity on osteogenic stem cells. The second space journey is scheduled to take place at the end of the year, and its purpose is to examine the impact of microgravity on different cell types involved in bone production or loss. An experimental chemical will undergo testing for its potential application in the treatment of bone loss in a microgravity environment.
In September 2023, Fujitsu Limited and iSurgery Co., Ltd. declared their intention to carry out a field trial for their "bone health promotion project" in collaboration with the Department of Orthopaedic Surgery at the Jikei University School of Medicine. This trial, scheduled to take place from October 2023 to March 2025, aims to assess the feasibility of using chest radiographs to evaluate bone health and examine the impact of this approach on the health-related attitudes and behaviors of Fujitsu employees. This is the first instance in Japan where an employer is prioritizing the enhancement of this particular area of their employees' health by utilizing chest radiographs for bone evaluations during their checkups. In this demonstration, the project group will apply iSurgery's AI medical device, the Chest Bone Indicator (3) (AI medical device), to evaluate bone health from chest radiographs and communicate the findings of health checkups for Fujitsu Group personnel. The project team will propose that employees undertake a comprehensive medical assessment by an expert, depending on the evaluation findings.
COVID 19 Analysis
Since the presence of the Covid pandemic, there has been a lot of changes in the manner individuals carried on with their lives, in the way the corporate world capacities, and in the way, the business and market units capacity and oblige the requirements of the separate crowd. The bone density test market is none other and is confronting the evil impacts brought about by the pandemic, also.
The interest is declined as the medical care specialist organizations and clinical staff like specialists and attendants are being redirected to treat individuals who have been determined to have the Covid sickness. Additionally, the pandemic has pushed individuals to achieve significant changes n their method of essential living and adjust their inclinations towards better and agreeable means. The worldwide legislatures are forcing severe limitations like the inconvenience of both long-lasting and transitory lockdown so the energy pace of the pandemic descends and life can be gone to predictability indeed.
The lockdown burden and severe useful limitations are functioning as the pace of inspiration is diminishing and the experts are returning to serve their insight in their subject matter. Likewise, the competitive and prominent players of the market are expanding their interest in the innovative work offices to concoct items and administrations that will help in giving a superior goal to the rising requirements of the main interest group during the ongoing forecast period that will be ending in 2030.
Drivers
The bone density test market trends show that there has been a rising prevalence of health concerns like osteoporosis, osteopenia, hyperthyroidism, along with an increasing demand for portable bone testing devices are likely to drive the bone density test market towards growth during the ongoing forecast period that will be ending in 2030. Also, the demand for diagnosis and treatment measures for osteoporosis, as a part of the market influences the market growth that has been predicted for the forecast period of 2022-2030. Additionally, the growing demand for technologically advanced devices drives the Bone Density Test Market growth during the forecast period.
Restraints
However, the bone density test market analysis shows that the market is likely to witness the emergence of some restraints that might hamper the bone density test market from growing as per the predictions for the ongoing forecast period. The bone density test market is understanding that factors like the high cost of bone densitometers are likely to restraint the market from growing as per the predictions. Also, there is a low degree of awareness that is further, causing growth and expansion issues for the bone density test market.
Technology Analysis
Bone density test offers more of a high-level overview and in-depth details and specifications on more specific aspects of bone health of an individual alongside the ability to indicate current and potential health risks that are inclusive of osteoporosis, low bone mineral density, and hyperthyroidism. A stress fracture or other bone issue is often one of the major reasons that can result in impaired bone health and could affect bone density in the future.
All these factors give a clear representation that a bone is not as strong as normal bone and further, it places that are at risk for stress fractures or other broken bones. Also, there have been ever-increasing population trends that are adopting the sedentary lifestyle and rising urbanization which are propelling the bone density market demand. Enhanced economic scenarios are fueling the bone density test market, thereby boosting the healthcare expenditures followed by facilitating rapid access to excellent healthcare amongst the global locations.
Study Objectives
The bone density test market functions in the form of the following market segments during the ongoing forecast period in the global market premises:
The bone density test market has been segmented based on the type and includes DXA Systems, Peripheral Bone Densitometers, Radiographic absorptiometry scanners, and others like Quantitative ultrasound scanners.
The application segment of the bone density test market includes osteoporosis and osteopenia Diagnosis, Cystic Fibrosis Diagnosis, Body Composition Measurement, alongside Rheumatoid Arthritis Diagnosis.
The bone density test market includes demand from Hospitals and Specialty Clinics, Diagnostic and Imaging Centers, amongst other End Users.
The market in the Asia Pacific is projected to grow at the highest CAGR during the forecast period of 2022-2030. The Asian countries particularly China and India are projected to offer significant growth opportunities for the prominent players of the bone density test market. The main reason behind this is the rising geriatric population, increasing incidence of osteoporosis, increasing healthcare expenditure, alongside the growing number of hospitals and clinics.
Key Players in the Global Bone Density Test Market
The bone density test market share is rising because of the splendid performance of the following players of the market:
Recent Developments
Intended Audience
Report Overview
The bone density test market report discusses the possible market dynamics like the drivers and restraints that have both positives and negatives to the market amid the ongoing forecast period of 2022-2030. The report covers the impact of the coronavirus outbreak on the market followed by the developments of the industry for the forecast period.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)